Recently there has been increasing evidence for an association between IRF8 and dendritic cell deficiencies leading to diseases such as chronic myelogenous leukemia [92], atherosclerosis [93], and cancers [42,94]. Here, IRF8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.